265 related articles for article (PubMed ID: 16797489)
1. KR-62980: a novel peroxisome proliferator-activated receptor gamma agonist with weak adipogenic effects.
Kim KR; Lee JH; Kim SJ; Rhee SD; Jung WH; Yang SD; Kim SS; Ahn JH; Cheon HG
Biochem Pharmacol; 2006 Aug; 72(4):446-54. PubMed ID: 16797489
[TBL] [Abstract][Full Text] [Related]
2. PAM-1616, a selective peroxisome proliferator-activated receptor γ modulator with preserved anti-diabetic efficacy and reduced adverse effects.
Kim MK; Chae YN; Choi SH; Moon HS; Son MH; Bae MH; Choi HH; Hur Y; Kim E; Park YH; Park CS; Kim JG; Lim JI; Shin CY
Eur J Pharmacol; 2011 Jan; 650(2-3):673-81. PubMed ID: 20974124
[TBL] [Abstract][Full Text] [Related]
3. A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties.
Fujimura T; Kimura C; Oe T; Takata Y; Sakuma H; Aramori I; Mutoh S
J Pharmacol Exp Ther; 2006 Aug; 318(2):863-71. PubMed ID: 16682454
[TBL] [Abstract][Full Text] [Related]
4. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
[TBL] [Abstract][Full Text] [Related]
5. 18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice.
Anandharajan R; Sayyed SG; Doshi LS; Dixit P; Chandak PG; Dixit AV; Brahma MK; Deshmukh NJ; Gupte R; Damre A; Suthar J; Padigaru M; Sharma SD; Nemmani KV
Metabolism; 2009 Oct; 58(10):1503-16. PubMed ID: 19608207
[TBL] [Abstract][Full Text] [Related]
6. PAR-1622 is a selective peroxisome proliferator-activated receptor gamma partial activator with preserved antidiabetic efficacy and broader safety profile for fluid retention.
Kim MK; Chae YN; Kim HS; Choi SH; Son MH; Kim SH; Kim JK; Moon HS; Park SK; Shin YA; Kim JG; Lee CH; Lim JI; Shin CY
Arch Pharm Res; 2009 May; 32(5):721-7. PubMed ID: 19471887
[TBL] [Abstract][Full Text] [Related]
7. Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells.
Choi SS; Cha BY; Lee YS; Yonezawa T; Teruya T; Nagai K; Woo JT
Life Sci; 2009 Jun; 84(25-26):908-14. PubMed ID: 19376135
[TBL] [Abstract][Full Text] [Related]
8. Bixin regulates mRNA expression involved in adipogenesis and enhances insulin sensitivity in 3T3-L1 adipocytes through PPARgamma activation.
Takahashi N; Goto T; Taimatsu A; Egawa K; Katoh S; Kusudo T; Sakamoto T; Ohyane C; Lee JY; Kim YI; Uemura T; Hirai S; Kawada T
Biochem Biophys Res Commun; 2009 Dec; 390(4):1372-6. PubMed ID: 19891958
[TBL] [Abstract][Full Text] [Related]
9. Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone (KR-66344).
Park JS; Rhee SD; Kang NS; Jung WH; Kim HY; Kim JH; Kang SK; Cheon HG; Ahn JH; Kim KY
Biochem Pharmacol; 2011 Apr; 81(8):1028-35. PubMed ID: 21315688
[TBL] [Abstract][Full Text] [Related]
10. NS-1: a novel partial peroxisome proliferator-activated receptor γ agonist to improve insulin sensitivity and metabolic profile.
Chaudhary S; Dube A; Kothari V; Sachan N; Upasani CD
Eur J Pharmacol; 2012 Jun; 684(1-3):154-60. PubMed ID: 22484334
[TBL] [Abstract][Full Text] [Related]
11. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
Kim MK; Chae YN; Son MH; Kim SH; Kim JK; Moon HS; Park CS; Bae MH; Kim E; Han T; Choi HH; Shin YA; Ahn BN; Lee CH; Lim JI; Shin CY
Eur J Pharmacol; 2008 Oct; 595(1-3):119-25. PubMed ID: 18727927
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of peroxisome proliferator-activated receptor gamma prevents high-fat diet-induced obesity in vivo.
Nakano R; Kurosaki E; Yoshida S; Yokono M; Shimaya A; Maruyama T; Shibasaki M
Biochem Pharmacol; 2006 Jun; 72(1):42-52. PubMed ID: 16696951
[TBL] [Abstract][Full Text] [Related]
13. Halofenate is a selective peroxisome proliferator-activated receptor gamma modulator with antidiabetic activity.
Allen T; Zhang F; Moodie SA; Clemens LE; Smith A; Gregoire F; Bell A; Muscat GE; Gustafson TA
Diabetes; 2006 Sep; 55(9):2523-33. PubMed ID: 16936200
[TBL] [Abstract][Full Text] [Related]
14. Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity.
Fang XK; Gao J; Zhu DN
Life Sci; 2008 Mar; 82(11-12):615-22. PubMed ID: 18262572
[TBL] [Abstract][Full Text] [Related]
15. Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling.
Moyers JS; Shiyanova TL; Mehrbod F; Dunbar JD; Noblitt TW; Otto KA; Reifel-Miller A; Kharitonenkov A
J Cell Physiol; 2007 Jan; 210(1):1-6. PubMed ID: 17063460
[TBL] [Abstract][Full Text] [Related]
16. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
Díaz-Delfín J; Morales M; Caelles C
Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
[TBL] [Abstract][Full Text] [Related]
17. The DLK gene is a transcriptional target of PPARγ.
Couture JP; Blouin R
Biochem J; 2011 Aug; 438(1):93-101. PubMed ID: 21585338
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of antihyperglycaemic and adverse effects of partial perioxisome proliferator-activated receptor (PPAR-gamma) agonist balaglitazone.
Larsen PJ; Lykkegaard K; Larsen LK; Fleckner J; Sauerberg P; Wassermann K; Wulff EM
Eur J Pharmacol; 2008 Oct; 596(1-3):173-9. PubMed ID: 18761337
[TBL] [Abstract][Full Text] [Related]
19. KR-62980 suppresses lipid metabolism through inhibition of cytosolic NADP isocitrate dehydrogenase in zebrafish.
Chun HS; Shin SH; Ahn S; Shin DS; Choi SS; Ahn JH; Bae MA
Zebrafish; 2014 Apr; 11(2):122-8. PubMed ID: 24588364
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of PPARgamma-TAZ interaction contributes to the anti-adipogenic activity of KR62980.
Jung H; Lee MS; Jang EJ; Ahn JH; Kang NS; Yoo SE; Bae MA; Hong JH; Hwang ES
Biochem Pharmacol; 2009 Nov; 78(10):1323-9. PubMed ID: 19591806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
